Low vitamin D was linked to bladder cancer risk, without proving prevention
Low blood levels were associated with greater risk. A separate analysis of higher levels was inconclusive, and evidence on dietary intake or supplements did not establish protection.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review linked low blood vitamin D with greater bladder cancer risk, but that association does not show that raising vitamin D prevents cancer. A separate analysis of higher levels was statistically inconclusive, and evidence on food intake or supplements remained unsettled. These are different questions and should not be treated as interchangeable.
Only the abstract was available. It does not specify the reference groups or follow-up periods behind the pooled risk estimates, and its dietary and supplement evidence is explicitly inconclusive.
The evidence has overlapping layers
An umbrella review summarizes existing research reviews. Here, those reviews overlapped in their underlying studies and differed in design, populations and vitamin D measurements, so their findings do not represent entirely independent, uniform evidence.
An inconclusive result stays inconclusive
The higher-level analysis had an uncertainty range compatible with either lower or higher risk. Its nonsignificant result does not establish protection, absence of an association, or an effective blood-level target.
The original publication
Vitamin D and Bladder Cancer Risk: An Umbrella Review and Second Order Meta-Analysis.
Mancin S, Ferrara G, Palomares SM et al.
Cancer Med · 2026
- PubMed ID
- 41814462
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.